Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Givaudan seeks stevia flavor patents

This article was originally published in The Tan Sheet

Executive Summary

The Swiss flavor and fragrance firm applies to patent its advancements in blocking the bitter taste receptor that rebaudioside A triggers. Givaudan's flavor-masking technology "enhances the overall taste performance ... while reducing or eliminating the inherent sensory defects," the company says Feb. 12. Givaudan has more than 20 flavor ingredients that work against rebaudioside A's bitterness. Rebaudioside A sweeteners have been available in the U.S. since December 2008, but industry observers question whether consumers will accept stevia's aftertaste in certain food and beverage applications (1"The Tan Sheet" Dec. 22, 2008, p. 8)

You may also be interested in...

Stevia Products Roll Out As GRAS, But Must Win Over Consumer Sweet Tooth

Stevia-based sweeteners are enjoying a coming out party with FDA giving the go-ahead to Cargill's Truvia and Merisant's PureVia

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts